STAT: Gates Foundation and U.K. put $52 million toward project fighting drug-resistant bacteria
“A transatlantic initiative devoted to underwriting new antibiotics and other treatments to tackle drug-resistant infections in developing countries received a big boost today when the Bill & Melinda Gates Foundation and the U.K. government agreed to fund the effort. The CARB-X project, which was created two years ago and later secured $455 million in funding from the U.S. government and a public-private partnership in the U.K., is now slated to receive an additional $52 million that will also be invested in getting new treatments into humans in clinical trials…” (Silverman, 5/22).